GRI Bio Free Cash Flow (FCF) History (GRI)
GRI Bio reported −$10.2M in free cash flow for fiscal 2025, a decrease of $1.6M from the previous fiscal year.
View full GRI Bio company overviewGRI Bio free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$10.2M | −$1.6M | — | — |
| 2024 | 2024-12-31 | −$8.6M | $387,000 | — | — |
| 2023 | 2023-12-31 | −$9.0M | −$7.9M | — | — |
| 2022 | 2022-12-31 | −$1.1M | $7.2M | — | — |
| 2021 | 2021-12-31 | −$8.3M | −$4.6M | — | — |
| 2020 | 2020-12-31 | −$3.7M | — | — | −3708.00% |
GRI Bio quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$2.3M | −$1.5M | — | — |
| Q3 2023 | 2023-09-30 | −$1.3M | −$247,000 | — | — |
| Q3 2022 | 2022-09-30 | −$125,000 | $943,000 | — | — |
| Q3 2021 | 2021-09-30 | −$1.3M | −$521,000 | — | — |
| Q4 2020 | 2020-12-31 | −$808,000 | — | — | — |
| Q3 2020 | 2020-09-30 | −$1.1M | — | — | — |
| Q2 2020 | 2020-06-30 | −$1.1M | — | — | — |
| Q1 2020 | 2020-03-31 | −$768,000 | — | — | −768.00% |
GRI Bio free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$3.7M to −$10.2M, a net decrease of $6.5M. GRI Bio's latest reported quarter, Q3 2024, generated −$2.3M in free cash flow, a decrease of $1.5M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review GRI Bio filings at SEC.gov ↗